ArticleEFFICACY OF SOFOSBUVIR, DACLAVIR AND RIBAVIRIN IN TREATMENT OF HCV INFECTION WITH DIFFERENT STAGES OF LIVER DISEASE
ArticleEFFICACY OF SOFOSBUVIR, DACLAVIR AND RIBAVIRIN IN TREATMENT OF HCV INFECTION WITH DIFFERENT STAGES OF LIVER DISEASE
ArticleAssessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin.
ArticleAssessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin.
ArticlePegylated Interferon, Ribavirin, and Sofosbuvir Combination versus Pegylated Interferon, Ribavirin in the Management of Chronic Hepatitis C Egyptian Patients
ArticlePegylated Interferon, Ribavirin, and Sofosbuvir Combination versus Pegylated Interferon, Ribavirin in the Management of Chronic Hepatitis C Egyptian Patients
ArticleSofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience
ArticleSofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience
ArticlePattern of Response to Sofosbuvir and Daclatasvir +/- Ribavirin Regimen in Chronic Hepatitis C Patients
ArticlePattern of Response to Sofosbuvir and Daclatasvir +/- Ribavirin Regimen in Chronic Hepatitis C Patients
ArticleEfficacy and Safety in Difference Combination of Sofosbuvir in Treatment of Chronic Hepatitis C Virus
ArticleEfficacy and Safety in Difference Combination of Sofosbuvir in Treatment of Chronic Hepatitis C Virus
ArticleComparative Study between Triple Therapy (Peginterferon /Ribavirin/Sofosbuvir) and Dual Therapy (Simeprevir /Sofosbuvir) in Treatment of Chronic HCV Patients
ArticleComparative Study between Triple Therapy (Peginterferon /Ribavirin/Sofosbuvir) and Dual Therapy (Simeprevir /Sofosbuvir) in Treatment of Chronic HCV Patients
ArticleEfficacy and Adverse Effects of Sofosbuvir-Based Therapies (Double and Triple Regimens) in Chronic HCV Patients
ArticleEfficacy and Adverse Effects of Sofosbuvir-Based Therapies (Double and Triple Regimens) in Chronic HCV Patients
ArticleEFFECT OF DIRECT ACTING ANTIVIRAL (SOFOSBUVIR) ON DAILY LIVING ACTIVITIES OF PATIENTS WITH HEPATITIS C VIRUS
ArticleEFFECT OF DIRECT ACTING ANTIVIRAL (SOFOSBUVIR) ON DAILY LIVING ACTIVITIES OF PATIENTS WITH HEPATITIS C VIRUS